Dyne Therapeutics, INC. (DYN) SEC Filings — 2024
31 SEC filings for Dyne Therapeutics, INC. (DYN) in 2024.
Filings
- Dyne Therapeutics, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Dyne Therapeutics, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Dyne Therapeutics Files 8-K — 8-K · Nov 12, 2024
- Dyne Therapeutics, INC. SC 13G Filing — SC 13G · Nov 12, 2024
- Dyne Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Oct 22, 2024
- Dyne Therapeutics, INC. 8-K Filing — 8-K · Sep 3, 2024
- Dyne Therapeutics Q2 2024 Update — 10-Q · Aug 12, 2024
- Dyne Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · May 24, 2024
- Dyne Therapeutics Files 8-K: Material Agreement & Other Events — 8-K · May 22, 2024
- Dyne Therapeutics Partners with Pfizer for DMD Drug — 8-K · May 20, 2024
- Dyne Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Dyne Therapeutics Announces 2024 Annual Meeting of Stockholders on May 22 — DEF 14A · Apr 5, 2024
- Dyne Therapeutics, INC. SC 13G Filing — SC 13G · Apr 4, 2024
- Dyne Therapeutics Appoints New CEO, Dr. Kristin Yarema — 8-K · Mar 25, 2024
- Dyne Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 5, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Dyne Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- MPM BioVentures Trims Dyne Therapeutics Stake to 9.9% — SC 13G/A · Feb 12, 2024
- Atlas Venture Amends Dyne Therapeutics Stake as of Dec 31, 2023 — SC 13G/A · Feb 9, 2024
- BlackRock Discloses 9.9% Stake in Dyne Therapeutics — SC 13G · Jan 29, 2024
- Deep Track Capital Maintains 2M Share Stake in Dyne Therapeutics — SC 13G/A · Jan 19, 2024
- Dyne Therapeutics Files 8-K on Material Definitive Agreement — 8-K · Jan 5, 2024
- Dyne Therapeutics Files 8-K, Confirms Emerging Growth Status — 8-K · Jan 4, 2024
- Dyne Therapeutics Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 3, 2024